Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus - Wikidata - wikimedia - TriplyDB

Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus

Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus

http://www.wikidata.org/entity/Q33978084

about

Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.Rifampin combination therapy for nonmycobacterial infections.Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci.

P2860

Q24812064-F2FA669F-4A3D-41FC-9B82-E13D645926B0 Q34107094-A4B7360C-50E1-45F2-9CE9-0B88F9886E4A Q35165783-02A7231F-184F-4B44-9FAE-FA4246A5C4E3 Q37672039-08A2775C-3C59-4E1C-AAD2-F73B0BE95DDD Q39475063-D4D365CE-4672-4F5C-928F-FB5439683923 Q41913615-C9F6BF10-C095-4EEB-A0EB-E30B3B647D56 Q41992616-59767AEF-35D0-4D9E-BAC6-77D6AEC8B049

P2860

Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus

http://www.wikidata.org/entity/Q33978084

description

1999 nî lūn-bûn

@nan

1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Efficacy of levofloxacin for e ...... occus or Staphylococcus aureus

@ast

Efficacy of levofloxacin for e ...... occus or Staphylococcus aureus

@en

type

label

Efficacy of levofloxacin for e ...... occus or Staphylococcus aureus

@ast

Efficacy of levofloxacin for e ...... occus or Staphylococcus aureus

@en

prefLabel

Efficacy of levofloxacin for e ...... occus or Staphylococcus aureus

@ast

Efficacy of levofloxacin for e ...... occus or Staphylococcus aureus

@en

P1433

Q33978084-F6750E49-A7E7-49C8-8535-E91DBC2745EA

P1476

Q33978084-DC9AD3CD-A1ED-4D6C-8157-1815DF999EC5

P2093

Q33978084-57B57C84-14C8-4325-8ECB-4962FCEAA661

Q33978084-5A2746ED-D19F-4846-899B-161D63D8555F

Q33978084-B98D714D-52F7-4D75-9A26-3F5CD23C94D5

Q33978084-F1102665-8DE0-481D-B6BD-C8B49E300C7C

Q33978084-F7E6A409-55EE-4C3F-BC1E-8D4BA3252F0C

P2860

Q33978084-0575AEE6-F43C-4438-BB86-AE27F55A1BB1

Q33978084-20515348-EC3F-4BFF-AFF7-3096D34A6F69

Q33978084-33F38520-DF42-4B24-AA5F-9A4596ADE175

Q33978084-3E15440C-9297-4CA2-AB03-5FB1A9A7006F

Q33978084-44C37AB0-13E9-483C-B481-71A5DAD23E68

Q33978084-4D3C4D58-F716-47C8-A689-1D98CEF33CCC

Q33978084-5AD84896-3E0F-4EA1-BD61-A12BFBAADAA2

Q33978084-631C542F-F860-4213-A9E4-BA1D823E9318

Q33978084-6663422D-7A7A-439A-8495-D73E9E354101

Q33978084-6AD99342-2D21-449B-9FA4-771200B701C2

P304

Q33978084-68F8043F-FE41-4340-84C4-943F3D1B8CF1

P31

Q33978084-98FB570A-CD8A-4E65-9018-88E85861B153

P407

Q33978084-A6BF1750-95A6-49AA-AEC8-14DF3E4144A9

P433

Q33978084-216CD61C-1154-439D-BA68-F77BDF38D11D

P478

Q33978084-7E143629-0745-46FE-8F6A-B8A41147B0B5

P577

Q33978084-3DD5A913-4C04-4701-A4FE-5532DAA29030

P698

Q33978084-523F6D13-80BD-4A59-B013-7B8C83CDF927

P932

Q33978084-E0821FE6-C94B-49CA-BB0A-DE9A0E60F97D

P1433

Antimicrobial Agents and Chemotherapy

P1476

Efficacy of levofloxacin for e ...... occus or Staphylococcus aureus

@en

P2093

C Hackbarth

http://www.w3.org/2001/XMLSchema#string

H F Chambers

http://www.w3.org/2001/XMLSchema#string

L L Chow

http://www.w3.org/2001/XMLSchema#string

Liu

http://www.w3.org/2001/XMLSchema#string

Q Xiang

http://www.w3.org/2001/XMLSchema#string

P2860

Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus

Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus.

Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.

Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations.

Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.

Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model

Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches.

Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.

In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.

Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.

P304

2742-2746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10543757

http://www.w3.org/2001/XMLSchema#string

P932

89553

http://www.w3.org/2001/XMLSchema#string